DOR antagonism using naltrindole substantially reversed AD pathology caused by APP/Presenilin overexpression in mice, including memory deficits, reactive glia formation, Aβ production, and BACE1/γ-secretase activity in the brain (Teng et al., 2010). The gene discussed is BACE1; the disease is Alzheimer disease.